Structural characterization of nonactive site, TrkA-selective kinase inhibitors
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structural characterization of nonactive site, TrkA-selective kinase inhibitors
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 114, Issue 3, Pages E297-E306
Publisher
Proceedings of the National Academy of Sciences
Online
2016-12-31
DOI
10.1073/pnas.1611577114
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer
- (2016) Francesco Passiglia et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Discovery of Entrectinib: A New 3-Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor
- (2016) Maria Menichincheri et al. JOURNAL OF MEDICINAL CHEMISTRY
- (R)-2-Phenylpyrrolidine Substituted Imidazopyridazines: A New Class of Potent and Selective Pan-TRK Inhibitors
- (2015) Ha-Soon Choi et al. ACS Medicinal Chemistry Letters
- Acquired Resistance to the TRK Inhibitor Entrectinib in Colorectal Cancer
- (2015) M. Russo et al. Cancer Discovery
- Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases
- (2014) Sandra W Cowan-Jacob et al. Future Medicinal Chemistry
- Maximizing Diversity from a Kinase Screen: Identification of Novel and Selective pan-Trk Inhibitors for Chronic Pain
- (2014) Shawn J. Stachel et al. JOURNAL OF MEDICINAL CHEMISTRY
- COSMIC: exploring the world's knowledge of somatic mutations in human cancer
- (2014) Simon A. Forbes et al. NUCLEIC ACIDS RESEARCH
- TRKing Down an Old Oncogene in a New Era of Targeted Therapy
- (2014) Aria Vaishnavi et al. Cancer Discovery
- Assessing the range of kinase autoinhibition mechanisms in the insulin receptor family
- (2012) Stephen C. Artim et al. BIOCHEMICAL JOURNAL
- The Crystal Structures of TrkA and TrkB Suggest Key Regions for Achieving Selective Inhibition
- (2012) T. Bertrand et al. JOURNAL OF MOLECULAR BIOLOGY
- Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors
- (2012) M. McTigue et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Data processing and analysis with theautoPROCtoolbox
- (2011) Clemens Vonrhein et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Novel Benzimidazole Inhibitors Bind to a Unique Site in the Kinesin Spindle Protein Motor Domain
- (2010) Payal R. Sheth et al. BIOCHEMISTRY
- Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee
- (2010) Nancy E. Lane et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trk kinase inhibitors as new treatments for cancer and pain
- (2009) Tao Wang et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- The Juxtamembrane Region of the EGF Receptor Functions as an Activation Domain
- (2009) Monica Red Brewer et al. MOLECULAR CELL
- Targeting Nerve Growth Factor in Pain
- (2008) Judy J Watson et al. BIODRUGS
- Probing the binding mechanism and affinity of tanezumab, a recombinant humanized anti-NGF monoclonal antibody, using a repertoire of biosensors
- (2008) Yasmina Noubia Abdiche et al. PROTEIN SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now